BackCompuMed Overview
CompuMed, Inc.

CompuMed Return on Equity

Latest ROE for CompuMed: -9.24% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-9.24%

Return on Equity

-9.24%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

CompuMed (CMPD) FAQ

CompuMed (CMPD) currently reports a ROE of -9.24%. That is below the sector sector average of 11.64%. Use the charts on this page to explore CompuMed's ROE history and peer comparisons.

CompuMed's ROE of -9.24% is lower than the its sector sector average of 11.64%. That is roughly 179.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but CompuMed's current -9.24% should be judged against industry norms (sector average: 11.64%) and against CMPD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -9.24%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.64%. From there, open related valuation or income-statement pages for CompuMed, and consider following CMPD for alerts when major investors trade the stock.